LeMaitre Vascular, Inc.
LMAT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.09 | 1.39 | -21.50 | 0.00 |
| FCF Yield | 1.34% | 1.01% | 0.40% | 0.63% |
| EV / EBITDA | 80.92 | 92.51 | 113.57 | 110.82 |
| Quality | ||||
| ROIC | 2.75% | 2.24% | 1.83% | 1.96% |
| Gross Margin | 75.28% | 70.02% | 69.18% | 69.26% |
| Cash Conversion Ratio | 1.66 | 1.47 | 0.82 | 1.36 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.09% | 9.82% | 10.18% | 10.80% |
| Free Cash Flow Growth | 39.76% | 147.51% | -41.73% | 4.47% |
| Safety | ||||
| Net Debt / EBITDA | 6.05 | 7.21 | 8.85 | 7.94 |
| Interest Coverage | 15.66 | 12.43 | 9.79 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.21 | 0.34 | 0.33 | 0.31 |
| Cash Conversion Cycle | 449.32 | 296.76 | 315.15 | 333.27 |